Literature DB >> 27371670

Regulation of Cellular Metabolism and Hypoxia by p53.

Timothy J Humpton1, Karen H Vousden1.   

Abstract

The p53 protein is essential for the implementation of the cellular response to challenging environmental conditions. Reacting to stochastic nutrient stress, p53 integrates the activity of key metabolite-sensing pathways to coordinate an appropriate cell response. During starvation, p53 activity augments cell survival pathways, inhibits unnecessary growth, and promotes efficient nutrient generation, utilization, and conservation. Similarly, during oxygen stress, p53 facilitates redirection of cellular metabolism toward energy generation through nonoxidative means, the suppression of reactive oxygen species (ROS) generation, and ROS detoxification-promoting cell survival. However, if adverse conditions are too acute or persistent, p53 can switch roles to implement canonical cell killing. The ability of p53 to regulate metabolism is a powerful feature of p53 biology that can both promote cell survival and act as a check on the inappropriate proliferation of cancer cells.
Copyright © 2016 Cold Spring Harbor Laboratory Press; all rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27371670      PMCID: PMC4930918          DOI: 10.1101/cshperspect.a026146

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN: 2157-1422            Impact factor:   6.915


  146 in total

1.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

2.  Activation of AMP-activated protein kinase induces p53-dependent apoptotic cell death in response to energetic stress.

Authors:  Rintaro Okoshi; Toshinori Ozaki; Hideki Yamamoto; Kiyohiro Ando; Nami Koida; Sayaka Ono; Tadayuki Koda; Takehiko Kamijo; Akira Nakagawara; Harutoshi Kizaki
Journal:  J Biol Chem       Date:  2007-12-04       Impact factor: 5.157

3.  A model for p53-induced apoptosis.

Authors:  K Polyak; Y Xia; J L Zweier; K W Kinzler; B Vogelstein
Journal:  Nature       Date:  1997-09-18       Impact factor: 49.962

4.  Targeted disruption of p53 attenuates doxorubicin-induced cardiac toxicity in mice.

Authors:  Yukitaka Shizukuda; Satoaki Matoba; Omar Y Mian; Tammy Nguyen; Paul M Hwang
Journal:  Mol Cell Biochem       Date:  2005-05       Impact factor: 3.396

5.  AMP-activated protein kinase induces a p53-dependent metabolic checkpoint.

Authors:  Russell G Jones; David R Plas; Sara Kubek; Monica Buzzai; James Mu; Yang Xu; Morris J Birnbaum; Craig B Thompson
Journal:  Mol Cell       Date:  2005-04-29       Impact factor: 17.970

6.  p53 negatively regulates transcription of the pyruvate dehydrogenase kinase Pdk2.

Authors:  Tanupriya Contractor; Chris R Harris
Journal:  Cancer Res       Date:  2011-11-28       Impact factor: 12.701

7.  A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus.

Authors:  L D Mayo; D B Donner
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-14       Impact factor: 11.205

8.  p53 and TIGAR regulate cardiac myocyte energy homeostasis under hypoxic stress.

Authors:  Masaki Kimata; Satoaki Matoba; Eri Iwai-Kanai; Hideo Nakamura; Atsushi Hoshino; Mikihiko Nakaoka; Maki Katamura; Yoshifumi Okawa; Yuichiro Mita; Mitsuhiko Okigaki; Koji Ikeda; Tetsuya Tatsumi; Hiroaki Matsubara
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-10-08       Impact factor: 4.733

9.  p53 cannot be induced by hypoxia alone but responds to the hypoxic microenvironment.

Authors:  Yi Pan; Patricia R Oprysko; Andrew M Asham; Cameron J Koch; Marie Celeste Simon
Journal:  Oncogene       Date:  2004-06-24       Impact factor: 9.867

Review 10.  Reactive oxygen species: current knowledge and applications in cancer research and therapeutic.

Authors:  Andy T Y Lau; Ying Wang; Jen-Fu Chiu
Journal:  J Cell Biochem       Date:  2008-05-15       Impact factor: 4.429

View more
  54 in total

1.  Fructose-1,6-Bisphosphatase 2 Inhibits Sarcoma Progression by Restraining Mitochondrial Biogenesis.

Authors:  Peiwei Huangyang; Fuming Li; Pearl Lee; Itzhak Nissim; Aalim M Weljie; Anthony Mancuso; Bo Li; Brian Keith; Sam S Yoon; M Celeste Simon
Journal:  Cell Metab       Date:  2019-11-21       Impact factor: 27.287

Review 2.  Context is everything: extrinsic signalling and gain-of-function p53 mutants.

Authors:  Ivano Amelio; Gerry Melino
Journal:  Cell Death Discov       Date:  2020-03-23

Review 3.  An evolutionary perspective on immunometabolism.

Authors:  Andrew Wang; Harding H Luan; Ruslan Medzhitov
Journal:  Science       Date:  2019-01-11       Impact factor: 47.728

Review 4.  Ceramide Signaling and p53 Pathways.

Authors:  Kristen A Jeffries; Natalia I Krupenko
Journal:  Adv Cancer Res       Date:  2018-06-01       Impact factor: 6.242

5.  Essential amino acid supplementation alters the p53 transcriptional response and cytokine gene expression following total knee arthroplasty.

Authors:  Jonathan B Muyskens; Ari Winbush; Douglas M Foote; Douglas W Turnbull; Hans C Dreyer
Journal:  J Appl Physiol (1985)       Date:  2020-09-03

6.  Regulation of the Mdm2-p53 pathway by the ubiquitin E3 ligase MARCH7.

Authors:  Kailiang Zhao; Yang Yang; Guang Zhang; Chenfeng Wang; Decai Wang; Mian Wu; Yide Mei
Journal:  EMBO Rep       Date:  2018-01-02       Impact factor: 8.807

Review 7.  Salvation of the fallen angel: Reactivating mutant p53.

Authors:  Yang Li; Zhuoyi Wang; Yuchen Chen; Robert B Petersen; Ling Zheng; Kun Huang
Journal:  Br J Pharmacol       Date:  2019-02-28       Impact factor: 8.739

Review 8.  Clinical Outcomes of TP53 Mutations in Cancers.

Authors:  Ana I Robles; Jin Jen; Curtis C Harris
Journal:  Cold Spring Harb Perspect Med       Date:  2016-09-01       Impact factor: 6.915

Review 9.  Functional characterization of AMP-activated protein kinase signaling in tumorigenesis.

Authors:  Ji Cheng; Tao Zhang; Hongbin Ji; Kaixiong Tao; Jianping Guo; Wenyi Wei
Journal:  Biochim Biophys Acta       Date:  2016-09-25

10.  Mitochondrial fission causes cisplatin resistance under hypoxic conditions via ROS in ovarian cancer cells.

Authors:  Youngjin Han; Boyun Kim; Untack Cho; In Sil Park; Se Ik Kim; Danny N Dhanasekaran; Benjamin K Tsang; Yong Sang Song
Journal:  Oncogene       Date:  2019-08-13       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.